Neurorehabilitation Market is Set Touch USD 2.58 Billion as a Result of Huge Surge in Cases of Neurological Disorders Globally | Research by SNS Insider

Pune, March 10, 2023 (GLOBE NEWSWIRE) — As per SNS Insider research, the size of the Neurorehabilitation Market was evaluated at USD 1.29 billion in 2022, and it is anticipated to grow at a CAGR of 9% between 2023 and 2030, ultimately reaching USD 2.58 billion.    

Market Overview

Neurorehabilitation is a branch of medical rehabilitation that focuses on the recovery and rehabilitation of individuals who have experienced damage to their nervous system. This damage can be due to a variety of factors, such as stroke, traumatic brain injury, spinal cord injury, multiple sclerosis, or Parkinson’s disease. The goal of neurorehabilitation is to help individuals regain as much independence and quality of life as possible. This is achieved through a combination of therapies and interventions that are tailored to the specific needs of each individual.

Market Analysis

Neurorehabilitation is a growing market due to several factors that are driving its growth. The rise in the number of neurological disorders and the growing awareness among patients and care providers are major contributors. With an increasing number of elderly people across the world, the target patient population is also growing. The rise in neurological disorders is a significant contributor to the growth of the neurorehabilitation market. The number of people diagnosed with neurological disorders is increasing, which has created a demand for advanced treatment options. With advancements in medical technology, care providers can now diagnose and treat these disorders more efficiently, leading to better patient outcomes.

Key Company Profiles Listed in this Report Are:

• Abbott Laboratories
• BioScience Managers Ltd
• Helius Medical Technologies
• Medtronic Inc
• Hocoma AG
• Ekso Bionics Holdings Inc
• Bionik Laboratories Corp and More

Request a Sample Report PDF of Neurorehabilitation Market@ https://www.snsinsider.com/sample-request/1261

Impact of COVID-19 Pandemic:

The pandemic has brought about a shift in the way healthcare services are delivered, including neurorehabilitation. With social distancing protocols in place, there has been an increased adoption of telemedicine and virtual therapy sessions, which have been instrumental in ensuring continued care for patients. Virtual rehabilitation services have become more prevalent, and this trend is expected to continue post-pandemic.

Neurorehabilitation Market Report Scope:

Do you have any queries related to this research report? Ask Your Query@ https://www.snsinsider.com/enquiry/1261

Key Regional Developments:

The neurorehabilitation market is experiencing significant growth, with North America being the largest regional segment. This growth is driven by several factors, including the increasing incidence rate of neurological diseases and a growing geriatric population. The Asia Pacific region is also poised to offer promising growth opportunities for the market. Companies are taking strategic initiatives to expand their operations in this region to tap into its potential.

Key Takeaway from Neurorehabilitation Market Study

• The global neurorehabilitation industry is seeing a rise in the demand for non-invasive methods of treatment. This trend is due to several factors, including advancements in non-invasive stimulators and increased awareness of the benefits of non-invasive treatment options.
• Hospitals have emerged as the dominant segment in the market, holding the largest market share. Hospitals offer comprehensive neurorehabilitation programs that include a range of therapies, such as physiotherapy, occupational therapy, speech therapy, and cognitive therapy.

Recent Developments Related to Neurorehabilitation Market

• Lupin, a leading pharmaceutical company, has recently opened a new neuro-rehabilitation center in India. The facility is designed to provide advanced treatment options and support for patients suffering from neurological disorders. The center’s launch is a significant step towards improving the standard of care for patients with neurological disorders in India. It highlights the growing need for specialized care and support for individuals affected by these conditions.
• MindMaze, a Swiss-based neuroscience company, has recently launched its Izar neurological rehabilitation device in the United States and Europe. The innovative technology is designed to help patients recover from neurological conditions and injuries by providing personalized and immersive therapy. The launch of the Izar device in the United States and Europe is a significant step forward in the field of neurological rehabilitation. The device’s innovative technology has the potential to revolutionize the way patients recover from neurological conditions and injuries.

Table of Contents – Major Key Points

1. Introduction

2. Research Methodology

3. Market Dynamics

4. Impact Analysis

5. Value Chain Analysis

6. Porter’s 5 Forces Model

7. PEST Analysis 

8. Neurorehabilitation Market Segmentation, By Type

9. Neurorehabilitation Market Segmentation, By Application Type

10. Neurorehabilitation Market Segmentation, By End-User Type

11. Regional Analysis

12. Company Profiles

13. Competitive Landscape

14. Conclusion

Buy Single-User PDF of Neurorehabilitation Market Report@ https://www.snsinsider.com/checkout/1261

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.